CoChat
Sign Up
Cited by 232

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

New and emerging roles for mast cells in host defence

Dawicki, Wojciech, Marshall, Jean S·2007·Current Opinion in Immunology
DOI 10.1016/j.coi.2006.11.006
Open this paper in CoChat — free account

Abstract

Mast cells are highly effective sentinel cells, found close to blood vessels and especially common sites of potential infection, such as the skin, airways and gastrointestinal tract. Mast cells participate actively in the innate immune responses to many pathogens through a broad spectrum of mediators that can be selectively generated. They also have a role as innate effector cells in enhancing the earliest processes in the development of acquired immune responses. Studies of bacterial and parasitic models have revealed mast cell dependent regulation of effector cell recruitment, mucosal barrier function and lymph node hypertrophy. An important role for mast cells in viral infection is also implied by several in vivo and in vitro studies. There are multiple direct and indirect pathways by which mast cells can be selectively activated by pathogens including Toll-like receptors, co-receptors and complement component receptors. Understanding the mechanisms and scope of the contribution of mast cells to host defence will be crucial to regulating their activity therapeutically.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.coi.2006.11.006

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 1 references

Research works printed but not linked: 76

  1. Marshall, 2004, Mast cells in innate immunity, J Allergy Clin Immunol, 114, 21, 10.1016/j.jaci.2004.04.045 · DOI
  2. Marshall, 2004, Mast-cell responses to pathogens, Nat Rev Immunol, 4, 787, 10.1038/nri1460 · DOI
  3. Vliagoftis, 2005, Mast cells at mucosal frontiers, Curr Mol Med, 5, 573, 10.2174/1566524054863915 · DOI
  4. Galli, 2005, Mast cells in the development of adaptive immune responses, Nat Immunol, 6, 135, 10.1038/ni1158 · DOI
  5. Galli, 2005, Mast cells as “tunable” effector and immunoregulatory cells: recent advances, Annu Rev Immunol, 23, 749, 10.1146/annurev.immunol.21.120601.141025 · DOI · Paper page
  6. Echtenacher, 1996, Critical protective role of mast cells in a model of acute septic peritonitis, Nature, 381, 75, 10.1038/381075a0 · DOI
  7. Malaviya, 1996, Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α, Nature, 381, 77, 10.1038/381077a0 · DOI
  8. Grimbaldeston, 2005, Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo, Am J Pathol, 167, 835, 10.1016/S0002-9440(10)62055-X · DOI · Paper page
  9. Tsai, 2005, Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo, Chem Immunol Allergy, 87, 179, 10.1159/000087644 · DOI
  10. Saito, 1996, Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells, J Immunol, 157, 343, 10.4049/jimmunol.157.1.343 · DOI
  11. Okayama, 2000, Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ, J Immunol, 164, 4332, 10.4049/jimmunol.164.8.4332 · DOI
  12. Kirshenbaum, 2003, Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcɛRI or FcγRI, Leuk Res, 27, 677, 10.1016/S0145-2126(02)00343-0 · DOI
  13. Wei, 2005, Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium, Infect Immun, 73, 1978, 10.1128/IAI.73.4.1978-1985.2005 · DOI
  14. Velin, 2005, Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model, Gastroenterology, 129, 142, 10.1053/j.gastro.2005.04.010 · DOI
  15. Ebmeyer, 2005, Role of mast cells in otitis media, J Allergy Clin Immunol, 116, 1129, 10.1016/j.jaci.2005.07.026 · DOI
  16. Albiin, 1986, Middle ear mucosa in rats and humans, Ann Otol Rhinol Laryngol Suppl, 126, 2, 10.1177/00034894860950S501 · DOI
  17. Xu, 2006, Mast cells protect mice from Mycoplasma pneumonia, Am J Respir Crit Care Med, 173, 219, 10.1164/rccm.200507-1034OC · DOI
  18. Jenkins, 2004, Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism, J Biol Chem, 279, 37201, 10.1074/jbc.M405594200 · DOI
  19. King, 2000, Release of vasoactive cytokines by antibody enhanced dengue virus infection of a human mast cell/basophil line, J Virol, 74, 7146, 10.1128/JVI.74.15.7146-7150.2000 · DOI
  20. King, 2002, Dengue virus selectively induces human mast cell chemokine production, J Virol, 76, 8408, 10.1128/JVI.76.16.8408-8419.2002 · DOI
  21. Brown MA, King CA, Marshall JS, Anderson RP: Fcγ receptor II mediates human mast cell dengue virus infection. J Leukoc Biol 2006, in press.
  22. Bannert, 2001, Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro, J Virol, 75, 10808, 10.1128/JVI.75.22.10808-10814.2001 · DOI
  23. Marone, 2001, Dysregulation of the IgE/FcɛRI network in HIV-1 infection, J Allergy Clin Immunol, 107, 22, 10.1067/mai.2001.111589 · DOI
  24. Li, 2001, Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4, Blood, 97, 3484, 10.1182/blood.V97.11.3484 · DOI
  25. Sundstrom, 2004, Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells, J Immunol, 172, 4391, 10.4049/jimmunol.172.7.4391 · DOI
  26. Genovese, 2003, Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells, Int Arch Allergy Immunol, 132, 336, 10.1159/000074901 · DOI
  27. Marone, 2001, Are mast cells MASTers in HIV-1 infection?, Int Arch Allergy Immunol, 125, 89, 10.1159/000053802 · DOI
  28. Li, 2004, Mast cell-dependent control of Giardia lamblia infections in mice, Infect Immun, 72, 6642, 10.1128/IAI.72.11.6642-6649.2004 · DOI
  29. McDermott, 2003, Mast cells disrupt epithelial barrier function during enteric nematode infection, Proc Natl Acad Sci USA, 100, 7761, 10.1073/pnas.1231488100 · DOI
  30. Lawrence, 2004, Mouse mast cell protease-1 is required for the enteropathy induced by gastrointestinal helminth infection in the mouse, Gastroenterology, 127, 155, 10.1053/j.gastro.2004.04.004 · DOI
  31. Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
  32. Sasaki, 2005, IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity, J Exp Med, 202, 607, 10.1084/jem.20042202 · DOI
  33. Onah, 2004, Mucosal mast cell-derived chondroitin sulphate levels in and worm expulsion from FcRγ-knockout mice following oral challenge with Strongyloides venezuelensis, J Vet Sci, 5, 221
  34. Pennock, 2004, In vivo exit of c-kit+/CD49dhi/beta7+ mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis, Blood, 103, 2655, 10.1182/blood-2003-09-3146 · DOI
  35. Jolly, 2004, Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome, Vet Immunol Immunopathol, 97, 125, 10.1016/j.vetimm.2003.08.014 · DOI
  36. Suto, 2006, Mast cell-associated TNF promotes dendritic cell migration, J Immunol, 176, 4102, 10.4049/jimmunol.176.7.4102 · DOI
  37. Jawdat, 2004, IgE-mediated mast cell activation induces Langerhans cell migration in vivo, J Immunol, 173, 5275, 10.4049/jimmunol.173.8.5275 · DOI
  38. Bryce, 2004, Immune sensitization in the skin is enhanced by antigen-independent effects of IgE, Immunity, 20, 381, 10.1016/S1074-7613(04)00080-9 · DOI
  39. Jawdat, 2006, Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan, J Immunol, 177, 1755, 10.4049/jimmunol.177.3.1755 · DOI
  40. McLachlan, 2003, Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection, Nat Immunol, 4, 1199, 10.1038/ni1005 · DOI
  41. Demeure, 2005, Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia, J Immunol, 174, 3932, 10.4049/jimmunol.174.7.3932 · DOI
  42. Depinay, 2006, Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites, J Immunol, 176, 4141, 10.4049/jimmunol.176.7.4141 · DOI
  43. Nakae, 2006, Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF, J Immunol, 176, 2238, 10.4049/jimmunol.176.4.2238 · DOI
  44. Nakae, 2005, Mast cells enhance T cell activation: importance of mast cell-derived TNF, Proc Natl Acad Sci USA, 102, 6467, 10.1073/pnas.0501912102 · DOI
  45. Gombert, 2005, CCL1–CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation, J Immunol, 174, 5082, 10.4049/jimmunol.174.8.5082 · DOI
  46. Orinska, 2005, TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment, Blood, 106, 978, 10.1182/blood-2004-07-2656 · DOI
  47. Mazzoni, 2001, Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization, J Clin Invest, 108, 1865, 10.1172/JCI200113930 · DOI
  48. Mazzoni, 2004, Controlling the Toll road to dendritic cell polarization, J Leukoc Biol, 75, 721, 10.1189/jlb.1003482 · DOI
  49. Lukacs, 2001, Role of chemokines in the pathogenesis of asthma, Nat Rev Immunol, 1, 108, 10.1038/35100503 · DOI
  50. McIlroy, 2006, Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-γ-induced CXCL10 production by immature human dendritic cells, Immunology, 117, 507, 10.1111/j.1365-2567.2006.02326.x · DOI
  51. Brightling, 2005, The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle, Am J Respir Crit Care Med, 171, 1103, 10.1164/rccm.200409-1220OC · DOI
  52. Weller, 2005, Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors, J Exp Med, 201, 1961, 10.1084/jem.20042407 · DOI
  53. Prodeus, 1997, Impaired mast cell-dependent natural immunity in complement C3-deficient mice, Nature, 390, 172, 10.1038/36586 · DOI
  54. Nilsson, 1996, C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway, J Immunol, 157, 1693, 10.4049/jimmunol.157.4.1693 · DOI
  55. Fujita, 2002, Evolution of the lectin-complement pathway and its role in innate immunity, Nat Rev Immunol, 2, 346, 10.1038/nri800 · DOI
  56. Edelson, 2006, Novel collectin/C1q receptor mediates mast cell activation and innate immunity, Blood, 107, 143, 10.1182/blood-2005-06-2218 · DOI
  57. Edelson, 2004, Mast cell-mediated inflammatory responses require the α2β1 integrin, Blood, 103, 2214, 10.1182/blood-2003-08-2978 · DOI
  58. Ali, 2000, Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT, J Immunol, 165, 7215, 10.4049/jimmunol.165.12.7215 · DOI
  59. Ahamed, 2004, C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1, J Immunol, 172, 6961, 10.4049/jimmunol.172.11.6961 · DOI
  60. Hartmann, 1997, C3a and C5a stimulate chemotaxis of human mast cells, Blood, 89, 2863, 10.1182/blood.V89.8.2863 · DOI
  61. Venkatesha, 2005, Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase, Mol Immunol, 42, 581, 10.1016/j.molimm.2004.09.009 · DOI
  62. Woolhiser, 2004, Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a, Clin Immunol, 110, 172, 10.1016/j.clim.2003.11.007 · DOI
  63. Andrasfalvy, 2005, The β subunit of the type I Fcɛ receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells, J Immunol, 175, 2801, 10.4049/jimmunol.175.5.2801 · DOI
  64. Erdei, 2004, Regulation of mast cell activation by complement-derived peptides, Immunol Lett, 92, 39, 10.1016/j.imlet.2003.11.019 · DOI
  65. Thangam, 2005, Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell–cell contact, FASEB J, 19, 798
  66. Kulka, 2004, Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3, J Allergy Clin Immunol, 114, 174, 10.1016/j.jaci.2004.03.049 · DOI
  67. McCurdy, 2003, Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells, J Immunol, 170, 1625, 10.4049/jimmunol.170.4.1625 · DOI
  68. Lin, 2003, Selective early production of CCL20, or macrophage inflammatory protein 3α, by human mast cells in response to Pseudomonas aeruginosa, Infect Immun, 71, 365, 10.1128/IAI.71.1.365-373.2003 · DOI
  69. Olynych, 2006, Dectin-1 mediated leukotriene production from human mast cells, J Allergy Clin Immunol, 118, 837, 10.1016/j.jaci.2006.06.008 · DOI
  70. Shimada, 2003, L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity, J Immunol, 170, 4325, 10.4049/jimmunol.170.8.4325 · DOI
  71. Okamoto, 2005, Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-β, Int Immunol, 17, 705, 10.1093/intimm/dxh250 · DOI
  72. Kanamaru, 2005, Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis, J Immunol, 174, 4193, 10.4049/jimmunol.174.7.4193 · DOI
  73. Gomez, 2005, TGF-β1 inhibits mast cell FcɛRI expression, J Immunol, 174, 5987, 10.4049/jimmunol.174.10.5987 · DOI
  74. Sly, 2004, LPS-induced upregulation of SHIP is essential for endotoxin tolerance, Immunity, 21, 227, 10.1016/j.immuni.2004.07.010 · DOI
  75. Brown, 2002, Dectin-1 is a major β-glucan receptor on macrophages, J Exp Med, 196, 407, 10.1084/jem.20020470 · DOI
  76. Gantner, 2003, Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2, J Exp Med, 197, 1107, 10.1084/jem.20021787 · DOI

Cited by

Sorted by citations

Metadata

Authors
Dawicki, W., & Marshall, J. S.
Venue
Current Opinion in Immunology
Publisher
Elsevier BV
Published
2007-02
Volume
19
Issue
1
Pages
31-38
ISSN
0952-7915
DOI
10.1016/j.coi.2006.11.006
Cited by
232
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review